ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 77

Epigenome Profiling Reveals Robust Hypomethylation of Interferon Signature Genes in Lupus Neutrophils

Patrick Coit1, Sri Yalavarthi1, Wenpu Zhao2, Mariana J. Kaplan2 and Amr H. Sawalha1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: DNA Methylation, Epigenetics, interferons and neutrophils, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics, Genomics and Proteomics I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Lupus neutrophils play an important role in tissue damage (including glomerulonephritis and lupus skin involvement), as well as endothelial damage in lupus patients. Several studies have suggested altered functional capacity of lupus neutrophils compared to healthy controls, and the expansion of a neutrophil subset with a lower density (low density granulocytes  or LDGs) in lupus. We characterized the DNA methylome of normal-density neutrophils and LDGs from lupus patients, and age-, sex-, and ethnicity-matched healthy controls to gain insight into chromatin architectural differences and how these differences might alter neutrophil function and induce pathogenicity in lupus.

Methods: We included 8 lupus patients and 8 healthy age-, sex-, and ethnicity-matched controls for these studies. Low density granulocytes (LDGs) and normal-density neutrophils were isolated from each lupus patient, and normal-density neutrophils were isolated from healthy controls. Neutrophils and LDGs were extracted using density gradient centrifugation and magnetic bead separation with over 95% purity in every sample. DNA was extracted and bisulfite conversion performed. A genome-wide DNA methylation study was performed using the Illumina HumanMethylation 450 BeadChip array, which includes over 485,000 methylation sites across the entire genome. The array covers 99% of RefSeq genes, including promoter regions, 5′-UTR, first exon, gene body, and 3′-UTR. 96% of all CpG islands are also covered. Statistical and bioinformatics analysis was performed to identify differentially methylated loci, gene ontologies, and pathways.

Results: We identified 619 differentially methylated CpG sites in normal-density neutrophils between lupus patients and healthy matched controls. Very interestingly, we find a robust and consistent demethylation of interferon signature genes in both normal-density neutrophils and LDGs in lupus patients. The top 30 hypomethylated CpG sites in lupus neutrophils are presented in Table 1. These data suggest that the chromatin structure in lupus granulocytes supports the expression of higher levels of type-1 interferon regulated genes, and that neutrophils directly contribute to the interferon signature in lupus. Curiously, however, our data so far suggest that LDGs and normal-density neutrophils from lupus patients are virtually identical in their chromatic architecture with no methylation differences across the genome between these two distinct granulocyte subsets.

Description: D:asawalhaDesktoplupus neutrophils ACR abstract.png

Conclusion: We characterized the DNA methylome in lupus neutrophils for the first time and showed a pattern of robust demethylation of interferon signature genes in lupus patients supporting a pathogenic role for neutrophils in lupus.


Disclosure:

P. Coit,
None;

S. Yalavarthi,
None;

W. Zhao,
None;

M. J. Kaplan,
None;

A. H. Sawalha,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epigenome-profiling-reveals-robust-hypomethylation-of-interferon-signature-genes-in-lupus-neutrophils/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology